Related Experiment Video
Updated: May 6, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Poor Prestroke Glycemic Control Increases the Rate of Symptomatic Intracranial Hemorrhage after Mechanical
Piotr Luchowski1, Maciej Szmygin2, Elzbieta Barton1
1Department of Neurology and Neurological Nursing, Medical University of Lublin, 20-954 Lublin, Poland.
Insights
Poor glycemic control in diabetic patients with acute ischemic stroke (AIS) did not affect 3-month outcomes after mechanical thrombectomy (MT). However, poorly controlled diabetes increased the risk of symptomatic intracranial hemorrhage following treatment.
Area of Science:
- Neurology
- Endovascular Therapy
- Metabolic Disorders
Background:
- Diabetes mellitus is a significant risk factor for acute ischemic stroke (AIS).
- Prestroke glycemic control may influence outcomes in diabetic patients undergoing mechanical thrombectomy (MT).
Purpose of the Study:
- To evaluate the impact of prestroke glycemic control on 3-month clinical outcomes in diabetic patients treated with MT for AIS.
- To assess the relationship between glycemic control and stroke severity, reperfusion rates, symptomatic intracranial hemorrhage (sICH), and functional outcomes.
Main Methods:
- Retrospective analysis of AIS patients (mRS 0-2) treated with MT within 6 hours of onset (Jan 2020 - Aug 2023).
- Patients were categorized into non-diabetes (ND), well-controlled diabetes (WCD), and poorly controlled diabetes (PCD) groups.
- Outcomes assessed included stroke severity (NIHSS), reperfusion, sICH, and modified Rankin Scale (mRS) at 3 months.
Main Results:
- No significant differences in baseline NIHSS or time to groin puncture among ND, WCD, and PCD groups.
- Favorable 3-month outcomes (mRS 0-2) and full recovery rates were similar across all groups.
- Symptomatic intracranial hemorrhage (sICH) rates were significantly higher in the PCD group compared to ND and WCD groups (21.7% vs. 7.6% and 6.0%, respectively).
- 3-month mortality did not differ significantly between the groups.
Conclusions:
- Poor prestroke glycemic control in diabetic AIS patients does not adversely affect 3-month functional outcomes after MT.
- Diabetic patients with poor glycemic control face an elevated risk of hemorrhagic complications post-MT.
- Careful consideration of bleeding risk is warranted in diabetic patients with poor glycemic control undergoing endovascular treatment.
Abstract:
(1) Background: Diabetes is a well-established risk factor for acute ischemic stroke (AIS). This study evaluated the impact of prestroke glycemic control in diabetic patients on their 3-month clinical outcome after mechanical thrombectomy (MT). (2) Methods: AIS patients with a premorbid modified Rankin scale (mRS) score of 0-2 who were admitted within 6 h after stroke onset and treated with MT between January 2020 and August 2023 were retrospectively analyzed. The study evaluated the effect of prestroke glycemic control on the stroke severity, reperfusion rate, symptomatic intracranial hemorrhage (sICH) and favorable clinical outcome (modified Rankin scale score 0-2) at 3 months after endovascular treatment. (3) Results: A total of 364 patients were analyzed, with 275 cases of non-diabetes (ND), 66 of well-controlled diabetes (WCD) and 23 of poorly controlled diabetes (PCD). There was no significant difference in the baseline neurological deficit expressed according to the National Institutes of Health Stroke Scale among the three groups. The time from stroke onset to groin puncture was similar in the ND, WCD and PCD groups (median 215 min, 194.5 min and 222.5 min, respectively). There was no significant difference in the favorable 3-month clinical outcomes among these three groups (35.2% of ND patients, 42.4% of WCD patients and 39.1% of PCD patients) or full recovery (12.4% of ND patients, 11.0% of WCD patients and 17.4% of PCD patients). The rate of sICH was significantly higher in the PCD group as compared to the ND and WDP groups (21.7% of PCD patients versus 7.6% of ND patients, p = 0.038, and 6.0% of WCD patients, p = 0.046), but the 3-month mortality did not differ between the three groups (21.8% of ND group, 19.7% of WCD group and 26.1% of PCD group). (4) Conclusions: This study shows that poor prestroke glycemic control in AIS diabetic patients does not change the chance of a good clinical functional outcome after endovascular treatment. However, the increased risk of hemorrhagic complications in this group of patients should be considered.
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

